Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Bushu Pharma's Collaboration with Suzuken Group Expands Services for Specialty Pharmaceuticals
2021-04-27 14:00
Hovid Berhad Partners with Esker to Automate its Accounts Payable Process
2021-04-27 09:35
DiscGenics Completes Patient Enrollment in Japanese Clinical Study of Cell Therapy for Disc Degeneration as US Study Achieves One-Year Follow-up Milestone
2021-04-27 09:23
Himalaya Therapeutics Announces Appointment of Brian Zhang as Chief Executive Officer
2021-04-26 22:08
CStone Announces NMPA Acceptance of New Drug Application of Selective Inhibitor GAVRETO(R) (Pralsetinib) with Priority Review Designation for the Treatment of Advanced or Metastatic RET-Altered Thyroid Cancer Patients
2021-04-26 21:14
I-Mab Announces Positive Topline Phase 2 Results for Olamkicept in Ulcerative Colitis
2021-04-26 19:00
INOVIO Planning for ex-US Global Phase 3 Trial for INO-4800
2021-04-23 20:00
Lipidor's subsidiary Emollivet takes the next step towards launch and receives funding from Vinnova
2021-04-23 15:22
The NDA of the Novel Anti-PD-1 mAb Serplulimab of Henlius Accepted by NMPA and Proposed to be Granted Priority Review
2021-04-23 15:00
The NDA of the Novel Anti-PD-1 mAb Serplulimab of Henlius Accepted by NMPA and Proposed to be Granted Priority Review
2021-04-22 21:47
Vaccines: More cooperation, less speculation
2021-04-22 21:00
RDIF and Minapharm agree to produce over 40 million doses of the Sputnik V vaccine in Egypt
2021-04-22 16:00
Seegene to supply COVID-19 diagnostic tests worth 16 mil. GBP to Scotland, triple the sales volume seen last year
2021-04-22 09:37
endpoint Launches ConnectionPOINT™ - A partnership program designed to power accelerated outcomes and move medicine through next-generation eClinical technology interfacing
2021-04-21 21:00
Cobots Lead the Future of the Global Industrial Robots Market, Finds Frost & Sullivan
2021-04-21 20:48
Samsung Biologics Celebrates Its 10th Anniversary with Its Mission, "Driven. For Life."
2021-04-21 19:00
GenScript ProBio Enters Collaboration with Singapore's Experimental Drug Development Centre to Develop Anti-Fibrosis Therapeutic Antibody Programme
2021-04-21 11:08
Ascentage Pharma to Announce Results from Four Clinical Studies at 2021 ASCO Annual Meeting, with Data of Its Drug Candidates Including Lisaftoclax (APG-2575) to Be Released in Oral Presentations for the First Time
2021-04-21 08:38
Clinical Trial Industry Veteran Paul Malan Joins Bioforum as Vice President of Biostatistics
2021-04-21 06:00
China Biologic Announces Completion of Going Private Transaction
2021-04-21 04:30
1
247
248
249
250
251
412